Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection-Reference-Cited by-同舟云学术

Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection

Published:2016-05-24 Issue:12 Volume:114 Page:1387-1394
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Cacheux Wulfran,Rouleau Etienne,Briaux Adrien,Tsantoulis Petros,Mariani Pascale,Richard-Molard Marion,Buecher Bruno,Dangles-Marie Virginie,Richon Sophie,Lazartigues Julien,Jeannot Emmanuelle,Farkhondeh Fereshteh,Sastre-Garau Xavier,de La Rochefordière Anne,Labib Alain,Falcou Marie-Christine,Stevens Denise,Roth Arnaud,Roman-Roman Sergio,Mitry Emmanuel,Bièche Ivan,Lièvre Astrid

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2016144.pdf

Reference53 articles.

1. Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, Aynaud O, Leocmach Y, Soubeyrand B, Dachez R, Riethmuller D, Mougin C, Pretet JL, Denis F (2011) Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer 129: 433–439.

2. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Treviño L, Drummond JA, Muzny DM, Wu Y, Wood LD, Hruban RH, Westra WH, Koch WM, Califano JA, Gibbs RA, Sidransky D, Vogelstein B, Velculescu VE, Papadopoulos N, Wheeler DA, Kinzler KW, Myers JN (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333: 1154–1157.

3. Aydin IT, Melamed RD, Adams SJ, Castillo-Martin M, Demir A, Bryk D, Brunner G, Cordon-Cardo C, Osman I, Rabadan R, Celebi JT (2014) FBXW7 mutations in melanoma and a new therapeutic paradigm. J Natl Cancer Inst 106: dju107.

4. Barmettler H, Komminoth P, Schmid M, Duerr D (2012) Efficacy of cetuximab in combination with FOLFIRI in a patient with KRAS wild-type metastatic anal cancer. Case Rep Oncol 5: 428–433.

5. Barault L, Veyrie N, Jooste V, Lecorre D, Chapusot C, Ferraz JM, Lièvre A, Cortet M, Bouvier AM, Rat P, Roignot P, Faivre J, Laurent-Puig P, Piard F (2008) Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers. Int J Cancer 122: 2255–2259.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic implications of HIF-1α expression in anal squamous cell carcinoma treated with intensity-modulated radiotherapy (IMRT);Clinical and Translational Radiation Oncology;2024-11

2. HPV status and immunohistochemical analysis of p16, p53 and PD‑L1 expression as prognostic biomarkers in patients with squamous cell anal cancer receiving definitive radiotherapy/chemoradiotherapy;Oncology Letters;2024-06-25

3. Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma;npj Precision Oncology;2024-04-23

4. Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with Chemoradiation;Journal of Clinical Medicine;2024-04-09

5. Progress in the treatment of anal cancer: an overview of the latest investigational drugs;Expert Opinion on Investigational Drugs;2024-01-30